CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹149 Cr | ₹129 Cr | ₹102 Cr | ₹100 Cr | ₹116 Cr |
What is the latest Long Term Provisions ratio of CIPLA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹149 Cr |
| Mar2024 | ₹129 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹100 Cr |
| Mar2021 | ₹116 Cr |
How is Long Term Provisions of CIPLA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹149 Cr | 15.03 | |
| Mar2024 | ₹129 Cr | 26.53 | |
| Mar2023 | ₹102 Cr | 1.94 | |
| Mar2022 | ₹100 Cr | -13.73 | |
| Mar2021 | ₹116 Cr | - | |
Compare Long Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹116,937.1 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹91,355.8 Cr | -4.3% | 1.5% | -21.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.3% |
-4.6% |
-1.5% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses